The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19

• Egile Nagusiak: Karen McCrae (Egilea), Stephanie Glegg (Egilea), Marie-Éve Goyer (Egilea), Bernard Le Foll (Egilea), Rupi Brar (Egilea), Christy Sutherland (Egilea), Nadia Fairbairn (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The dual COVID-19 and overdose emergencies amplified strain on healthcare systems tasked with responding to both. One downstream consequence of the pandemic in the USA and Canada was a surge in drug overdoses resulting from public health-restricted access to services and an incre...